
Helio Genomics Presents Three Abstracts on Early Cancer Detection with a Blood-Based Test at the 2025 Digestive Disease ...
IRVINE, Calif., May 1, 2025 /PRNewswire/ -- Helio Genomics ("Helio" or "the Company"), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today announced that they …